4//SEC Filing
Turner Christopher Durant 4
Accession 0000950170-25-003490
CIK 0001861560other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:50 PM ET
Size
12.6 KB
Accession
0000950170-25-003490
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Turner Christopher Durant
Chief Medical Officer
Transactions
- Sale
Class A Common Stock
2025-01-06$78.28/sh−1,152$90,179→ 65,411 total - Sale
Class A Common Stock
2025-01-06$80.54/sh−2,173$175,013→ 62,547 total - Award
Class A Common Stock
2025-01-06+18,750→ 66,563 total - Sale
Class A Common Stock
2025-01-06$79.33/sh−691$54,817→ 64,720 total - Award
Stock Option (Right to Buy)
2025-01-06+37,500→ 37,500 totalExercise: $78.09Exp: 2035-01-06→ Class A Common Stock (37,500 underlying)
Footnotes (6)
- [F1]Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following January 6, 2025, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
- [F2]The sale was effected pursuant to a durable Rule 10b5-1 sell-to-cover instruction letter entered into on December 6, 2023 to satisfy the reporting person's tax withholding obligations upon the vesting of previously granted equity awards.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.02 to $79.01, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (5) of this Form 4.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.02 to $79.97, inclusive.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.04 to $81.03, inclusive.
- [F6]The shares underlying this option vest over the four years following January 6, 2025 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
Related Parties
1- filerCIK 0001862146
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:50 PM ET
- Size
- 12.6 KB